Unraveling the Sweet Secrets of HCC: Glucometabolic Rewiring in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the primary form of liver cancer. It causes ∼ 800 000 deaths per year, which is expected to increase due to increasing rates of obesity and metabolic dysfunction associated steatotic liver disease (MASLD). Current therapies include immune checkpoint inhibitors, tyro...
Main Authors: | Sheraz Ahmad Bhat PhD, Zeenat Farooq PhD, Hagar Ismail BS, Irene Corona-Avila BS, Md. Wasim Khan PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-12-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/15330338231219434 |
Similar Items
-
Aiding Cancer’s “Sweet Tooth”: Role of Hexokinases in Metabolic Reprogramming
by: Zeenat Farooq, et al.
Published: (2023-04-01) -
Sweet Marjoram
by: Fatemeh Bina PharmD, PhD Candidate, et al.
Published: (2017-01-01) -
High Squalene Epoxidase in Tumors Predicts Worse Survival in Patients With Hepatocellular Carcinoma: Integrated Bioinformatic Analysis on NAFLD and HCC
by: Tingting Shen MD, et al.
Published: (2020-03-01) -
HCC-Check: A Novel Diagnostic Tool for Early Detection of Hepatocellular Carcinoma Based on Cytokeratin-1 and Epithelial Membrane Antigen: A Cross-Sectional Study
by: Kareem A. Attallah MSc, et al.
Published: (2024-03-01) -
HNRNPM Regulates HCC Tumorigenesis and Cancer Stemness: Identification of a Novel Therapeutic Target?
by: Lindsey Kennedy, PhD
Published: (2022-01-01)